Trademark: 76226598
Word
IPO IMPATH PREDICTIVE ONCOLOGY
Status
Dead
Status Code
710
Status Date
Saturday, February 6, 2010
Serial Number
76226598
Registration Number
2731185
Registration Date
Tuesday, July 1, 2003
Mark Type
3000
Filing Date
Monday, March 19, 2001
Published for Opposition
Tuesday, April 8, 2003
Cancellation Date
Saturday, February 6, 2010

Trademark Owner History
GENZYME CORPORATION -
IMPATH Inc. - Original Registrant

Classifications
42 Biopharmacogenomic services, namely research and development in targeted drug and diagnostic product discovery, drug development and diagnostic product and targeted therapies for others
"PREDICTIVE ONCOLOGY"
The mark consists of the stylized letters "IPO".

Trademark Events
Feb 6, 2010
Cancelled Sec. 8 (6-Yr)
Mar 18, 2008
Case File In Ticrs
Sep 20, 2006
Automatic Update Of Assignment Of Ownership
May 21, 2004
Teas Change Of Correspondence Received
Jul 1, 2003
Registered-Principal Register
Apr 8, 2003
Published For Opposition
Mar 19, 2003
Notice Of Publication
Jul 8, 2002
Approved For Pub - Principal Register
May 9, 2002
Paper Received
Feb 13, 2002
Correspondence Received In Law Office
Jul 8, 2002
Previous Action Count Withdrawn
Mar 13, 2002
Assigned To Examiner
Apr 25, 2001
Unresponsive/Duplicate Paper Received
Jun 15, 2001
Non-Final Action Mailed
Jun 14, 2001
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24